The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer


NCT02327819

Interventional

Not Applicable

Unknown status
Supplementation of BCAA found to reduce the risk of developing liver cancer, but the affect of BCAA on existing liver cancer is unknown. The participants (post curative intent surgery) will be supplemented with either BCAA/non-BCAA-enriched protein supplement. The intervantion will go on for 2 years or until a new liver tumor is found.
Jan 31,2015
All
18 Years
65 Years
60